Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$855M |
| 2 |
Samsara
IOT
|
$371M |
| 3 |
SolarEdge
SEDG
|
$272M |
| 4 |
Moderna
MRNA
|
$258M |
| 5 |
Floor & Decor
FND
|
$251M |
Top Sells
| 1 |
Salesforce
CRM
|
$439M |
| 2 |
Illumina
ILMN
|
$388M |
| 3 |
NVIDIA
NVDA
|
$379M |
| 4 |
FRC
First Republic Bank
FRC
|
$333M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$326M |
Sector Composition
| 1 | Consumer Discretionary | 27.8% |
| 2 | Healthcare | 22.38% |
| 3 | Technology | 21.76% |
| 4 | Communication Services | 11.88% |
| 5 | Financials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Albemarle
ALB
$9.99B
| $562M | 0.51% | 2,540,607 -164,109 | -6% | -$36.3M |
|
52
MarketAxess Holdings
MKTX
$6.87B
| $560M | 0.51% | 1,430,281 +2,978 | +0.2% | +$1.17M |
|
53
Teradyne
TER
$18.8B
| $533M | 0.48% | 4,956,197 -379,586 | -7% | -$40.8M |
|
54
Axon Enterprise
AXON
$58.7B
| $532M | 0.48% | 2,364,333 -179,209 | -7% | -$40.3M |
|
55
NovoCure
NVCR
$1.38B
| $517M | 0.47% | 8,603,501 -260,341 | -3% | -$15.7M |
|
56
S&P Global
SPGI
$167B
| $503M | 0.45% | 1,459,197 -105,581 | -7% | -$36.4M |
|
57
Booking.com
BKNG
$181B
| $490M | 0.44% | 184,610 -94,626 | -34% | -$251M |
|
58
10x Genomics
TXG
$1.74B
| $488M | 0.44% | 8,753,987 +151,752 | +2% | +$8.47M |
|
59
Mettler-Toledo International
MTD
$26.8B
| $488M | 0.44% | 319,144 -6,573 | -2% | -$10.1M |
|
60
Deere & Co
DE
$129B
| $473M | 0.43% | 1,144,687 -14,781 | -1% | -$6.1M |
|
61
Broadridge
BR
$29.9B
| $464M | 0.42% | 3,162,987 -246,278 | -7% | -$36.1M |
|
62
Datadog
DDOG
$47.7B
| $443M | 0.4% | 6,094,802 +324,130 | +6% | +$23.6M |
|
63
Elastic
ESTC
$9.04B
| $442M | 0.4% | 7,634,113 +1,723,842 | +29% | +$99.8M |
|
64
Cemex
CX
$13.2B
| $418M | 0.38% | 75,578,623 -4,962,178 | -6% | -$27.4M |
|
65
Markel Group
MKL
$24.8B
| $405M | 0.37% | 317,434 -32,620 | -9% | -$41.7M |
|
66
Baidu
BIDU
$32.8B
| $403M | 0.36% | 2,667,531 -3,038 | -0.1% | -$458K |
|
67
Charles Schwab
SCHW
$174B
| $398M | 0.36% | 7,602,843 -561,379 | -7% | -$29.4M |
|
68
CBRE Group
CBRE
$48.2B
| $395M | 0.36% | 5,429,124 -394,561 | -7% | -$28.7M |
|
69
Copa Holdings
CPA
$4.83B
| $372M | 0.34% | 4,022,774 -600,550 | -13% | -$55.5M |
|
|
70
Samsara
IOT
$20.6B
| $371M | 0.33% | +18,813,062 | New | +$371M |
|
71
Denali Therapeutics
DNLI
$2.23B
| $354M | 0.32% | 15,352,111 +232,637 | +2% | +$5.36M |
|
72
Eaton
ETN
$136B
| $339M | 0.31% | 1,980,627 +528,541 | +36% | +$90.6M |
|
73
Xylem
XYL
$34.5B
| $337M | 0.3% | 3,222,816 +74,563 | +2% | +$7.81M |
|
74
STAAR Surgical
STAA
$1.36B
| $328M | 0.3% | 5,124,341 -116,115 | -2% | -$7.43M |
|
75
Exact Sciences
EXAS
$8.98B
| $324M | 0.29% | 4,782,346 -148,916 | -3% | -$10.1M |
|